scholarly journals Treatment Option for Abernethy Malformation—Two Cases Report and Review of the Literature

2020 ◽  
Vol 8 ◽  
Author(s):  
Yuese Lin ◽  
Xuandi Li ◽  
Shujuan Li ◽  
Hongjun Ba ◽  
Huishen Wang ◽  
...  
Keyword(s):  
Treatment Option ◽  
Review Of The Literature ◽  
Abernethy Malformation

scholarly journals Surgery results in low relapse and progression rates in extramedullary plasmacytoma of the head and neck: A case cohort and review of the literature

2020 ◽  
Vol 12 (2) ◽  
Author(s):  
Matevz Skerget ◽  
Tadej Dovsak ◽  
Gregor Kos ◽  
Samo Zver
Keyword(s):  
Multiple Myeloma ◽  
Local Recurrence ◽  
Head And Neck ◽  
Treatment Option ◽  
Local Control ◽  
Extramedullary Plasmacytoma ◽  
Initial Evaluation ◽  
Review Of The Literature

Extramedullary plasmacytoma of the head and neck is a rare indolent neoplasm. Radiotherapy is often the preferred treatment option with excellent local control and survival. The risk of local recurrence or transformation to multiple myeloma is 10- 30%. In our case-cohort, thorough, sensitive initial evaluation for disseminated clonal disease and the incorporation of surgery led to excellent results with no recurrences or systemic progression.

scholarly journals A Case Report of Urinary Bladder Carcinosarcoma and Review of the Literature

2011 ◽  
Vol 2011 ◽  
pp. 1-3
Author(s):  
Christos Zachariadis ◽  
Ioannis Efthimiou ◽  
Stylianos Giannakopoulos ◽  
Athanasios Bantis ◽  
Alexandra Giatromanolaki ◽  
...  
Keyword(s):  
Case Report ◽  
Soft Tissue ◽  
Urinary Bladder ◽  
Treatment Option ◽  
Transurethral Resection ◽  
Case Reports ◽  
Review Of The Literature ◽  
Small Series ◽  
Radiotherapy Alone ◽  
Aggressive Tumors

Carcinosarcoma of the bladder is an unusual tumour characterized by a combination of malignant epithelial and soft tissue elements. Most of the reported cases have been case reports or small series. Optimal treatment is uncertain. We herein report our experience in such a case treated with transurethral resection followed by radiotherapy with adverse final outcome. Treatment of bladder carcinosarcomas should be aggressive and multimodal but optional treatment is still unknown. Radiotherapy alone is insufficient as a treatment option of these aggressive tumors.

Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature

2005 ◽  
Vol 85 (1) ◽  
pp. 1-16 ◽  
Author(s):  
Antonia M. S. Müller ◽  
Uwe M. Martens ◽  
Silke C. Hofmann ◽  
Leena Bruckner-Tuderman ◽  
Roland Mertelsmann ◽  
...  
Keyword(s):  
Imatinib Mesylate ◽  
Treatment Option ◽  
Case Reports ◽  
Hypereosinophilic Syndrome ◽  
Review Of The Literature ◽  
Comprehensive Review ◽  
Novel Treatment

scholarly journals Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature

2021 ◽  
Vol 19 (2) ◽  
pp. 114-117
Author(s):  
Andac Salman ◽  
Meryem Aktaş
Keyword(s):  
Pregnant Woman ◽  
Cohort Studies ◽  
Effective Treatment ◽  
Treatment Option ◽  
Congenital Abnormalities ◽  
Chronic Spontaneous Urticaria ◽  
Review Of The Literature ◽  
Effective Treatment Option ◽  
Increased Risk

ABSTRACT Omalizumab is a safe and effective treatment option for chronic spontaneous urticaria (CSU). Although cohort studies in patients with asthma show no increased risk of congenital abnormalities, very little data exist in the literature regarding the use of omalizumab for CSU during pregnancy. Herein, the safe and successful use of omalizumab updosing in a pregnant woman with CSU along with a review of the published literature is presented. Keywords: Chronic spontaneous urticaria, omalizumab, pregnancy, updosing

scholarly journals Enteral Topiramate in a Pediatric Patient with Refractory Status Epilepticus: A Case Report and Review of the Literature

2014 ◽  
Vol 19 (4) ◽  
pp. 317-324
Author(s):  
Chasity M. Shelton ◽  
Elizabeth L. Alford ◽  
Stephanie Storgion ◽  
James Wheless ◽  
Stephanie J. Phelps
Keyword(s):  
Case Report ◽  
Metabolic Acidosis ◽  
Status Epilepticus ◽  
Pediatric Patient ◽  
Treatment Option ◽  
Refractory Status Epilepticus ◽  
Convulsive Status Epilepticus ◽  
Review Of The Literature ◽  
Refractory Status

We describe the use of topiramate in a healthy 12-year-old (88-kg) male who developed refractory generalized convulsive status epilepticus. Seizures persisted despite aggressive use of benzodiazepines (intravenous lorazepam; oral clorazepate), barbiturates (i.e., phenobarbital, pentobarbital), and hydantoins. The child's seizures were controlled with nasogastrically administered topiramate in doses up to 500 mg twice daily (11.4 mg/kg/day). The patient did not display any clinical or laboratory signs of metabolic acidosis while receiving topiramate. Topiramate should be considered as a treatment option in refractory status epilepticus.

scholarly journals Involution of a Large Parotid Hemangioma with Oral Propranolol: An Illustrative Report and Review of the Literature

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Elpis Mantadakis ◽  
Emmanouela Tsouvala ◽  
Savas Deftereos ◽  
Vassilios Danielides ◽  
Athanassios Chatzimichael
Keyword(s):  
Parotid Gland ◽  
Treatment Option ◽  
Review Of The Literature ◽  
New Treatment ◽  
Oral Propranolol

Propranolol has emerged as a new treatment option for infantile hemangiomas. We describe a 20-month-old boy with a large right parotid hemangioma diagnosed at the age of 37 days. Starting at the age of 2.5 months, he received oral propranolol for 6.5 months. Although the mass regressed, it recurred when propranolol was discontinued. He was successfully retreated at the age of 11 months with propranolol for another 5.5 months without further recurrences. Treatment was tolerated well. Our paper and a review of the literature demonstrate that propranolol appears to be safe and effective for symptomatic infantile parotid gland hemangiomas.

Sign in / Sign up

Export Citation Format

Share Document